SWB timeline
Every SWB batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| SWB-2607-Y5787 | BPC-157 | 30 Jul 2026 | 2026-Q3 | 1 | 99.93 | n<2 | 99.90 | -0.03 | |
| SWB-2605-B4738 | MK-677 (Ibutamoren mesylate) | 31 May 2026 | 2026-Q2 | 2 | 99.47 | 0.29 | 99.90 | +0.43 | |
| SWB-2603-A5707 | Melanotan II | 30 Mar 2026 | 2026-Q3 | 13 | 99.16 | 1.30 | 99.71 | +0.55 | |
| SWB-2603-D6238 | Kisspeptin-10 | 20 Mar 2026 | 2026-Q3 | 10 | 98.56 | 1.58 | 98.99 | +0.43 | SHARED BULK |
| SWB-2603-T5632 | Semaglutide | 16 Mar 2026 | 2026-Q2 | 4 | 98.43 | 1.52 | 98.64 | +0.21 | |
| SWB-2603-D6146 | Exenatide | 03 Mar 2026 | 2026-Q3 | 1 | 98.70 | n<2 | 99.00 | +0.30 | |
| SWB-2602-X5278 | Semaglutide | 18 Feb 2026 | 2026-Q3 | 13 | 98.79 | 1.58 | 99.14 | +0.35 | |
| SWB-2602-J6019 | Melanotan II | 17 Feb 2026 | 2026-Q1 | 14 | 99.78 | 0.70 | 99.90 | +0.12 | |
| SWB-2602-W5529 | Semaglutide | 15 Feb 2026 | 2026-Q1 | 9 | 99.33 | 1.52 | 99.63 | +0.30 | |
| SWB-2602-P5992 | NAD+ | 07 Feb 2026 | 2026-Q2 | 4 | 98.98 | 0.58 | 98.82 | -0.16 | |
| SWB-2601-V4383 | Tirzepatide | 31 Jan 2026 | 2026-Q1 | 11 | 99.23 | 1.70 | 98.93 | -0.30 | |
| SWB-2601-Y5870 | IGF-1 DES (1-3) | 28 Jan 2026 | 2026-Q2 | 14 | 97.95 | 1.20 | 98.74 | +0.79 | |
| SWB-2601-D5672 | BPC-157 | 24 Jan 2026 | 2026-Q1 | 3 | 99.82 | 0.05 | 99.57 | -0.25 | |
| SWB-2601-J5083 | Cagrilintide | 14 Jan 2026 | 2026-Q2 | 1 | 99.15 | n<2 | 99.16 | +0.01 | |
| SWB-2601-E6319 | MGF | 08 Jan 2026 | 2026-Q1 | 12 | 98.41 | 1.39 | 99.08 | +0.67 | |
| SWB-2512-L5147 | Semaglutide | 10 Dec 2025 | 2026-Q1 | 8 | 97.93 | 1.48 | 98.26 | +0.33 | |
| SWB-2512-S5560 | CJC-1295 (no DAC) | 09 Dec 2025 | 2026-Q1 | 2 | 98.73 | 0.07 | 99.65 | +0.92 | |
| SWB-2511-N6092 | BPC-157 | 29 Nov 2025 | 2025-Q4 | 12 | 98.78 | 1.38 | 99.82 | +1.04 | |
| SWB-2511-C5170 | Selank | 26 Nov 2025 | 2025-Q4 | 12 | 99.15 | 1.27 | 99.75 | +0.60 | |
| SWB-2511-B4697 | Semaglutide | 20 Nov 2025 | 2025-Q4 | 4 | 98.18 | 0.52 | 98.79 | +0.61 | |
| SWB-2511-Y5187 | CJC-1295 with DAC | 07 Nov 2025 | 2026-Q2 | 1 | 98.72 | n<2 | 99.04 | +0.32 | |
| SWB-2510-N4367 | CJC-1295 with DAC | 27 Oct 2025 | 2026-Q1 | 4 | 98.33 | 0.85 | 98.70 | +0.37 | |
| SWB-2510-U5063 | IGF-1 LR3 | 05 Oct 2025 | 2025-Q4 | 4 | 98.25 | 1.10 | 98.38 | +0.13 | |
| SWB-2507-E6159 | 5-Amino-1MQ | 24 Jul 2025 | 2025-Q3 | 6 | 99.49 | 1.16 | 99.90 | +0.41 | |
| SWB-2506-B5296 | L-Glutathione (reduced) | 27 Jun 2025 | 2025-Q4 | 10 | 98.79 | 1.61 | 98.96 | +0.17 | SHARED BULK |
| SWB-2505-U4985 | N-Acetyl Semax Amide | 25 May 2025 | 2025-Q2 | 4 | 99.54 | 0.64 | 99.70 | +0.16 | |
| SWB-2505-R5948 | Tirzepatide | 15 May 2025 | 2025-Q2 | 1 | 99.36 | n<2 | 99.14 | -0.22 | |
| SWB-2505-N5257 | IGF-1 LR3 | 08 May 2025 | 2025-Q4 | 11 | 97.00 | 1.32 | 97.40 | +0.40 | |
| SWB-2505-Y5355 | Mazdutide | 04 May 2025 | 2025-Q4 | 8 | 98.27 | 0.70 | 98.64 | +0.37 | |
| SWB-2505-G5727 | MK-677 (Ibutamoren mesylate) | 01 May 2025 | 2025-Q3 | 1 | 99.16 | n<2 | 99.90 | +0.74 | |
| SWB-2504-F5003 | AOD-9604 | 22 Apr 2025 | 2025-Q3 | 3 | 98.96 | 0.35 | 99.56 | +0.60 | |
| SWB-2504-W4423 | N-Acetyl Semax Amide | 20 Apr 2025 | 2025-Q2 | 3 | 99.06 | 0.89 | 99.59 | +0.53 | |
| SWB-2504-M6687 | BPC-157 | 18 Apr 2025 | 2025-Q2 | 5 | 99.65 | 0.75 | 99.90 | +0.25 | |
| SWB-2504-Y4284 | Semaglutide | 16 Apr 2025 | 2025-Q3 | 5 | 99.72 | 0.86 | 99.90 | +0.18 | |
| SWB-2503-P4938 | Retatrutide | 22 Mar 2025 | 2025-Q2 | 9 | 98.32 | 1.53 | 98.98 | +0.66 | |
| SWB-2503-S5672 | Thymosin α1 | 19 Mar 2025 | 2025-Q3 | 9 | 99.30 | 0.75 | 99.22 | -0.08 | |
| SWB-2502-N4413 | AOD-9604 | 26 Feb 2025 | 2025-Q1 | 6 | 99.16 | 0.83 | 99.64 | +0.48 | |
| SWB-2501-Y4965 | Ipamorelin | 29 Jan 2025 | 2025-Q2 | 12 | 99.85 | 0.56 | 99.90 | +0.05 | |
| SWB-2501-G5396 | 5-Amino-1MQ | 01 Jan 2025 | 2025-Q2 | 6 | 99.28 | 1.11 | 99.14 | -0.14 | |
| SWB-2411-S5667 | Gonadorelin | 27 Nov 2024 | 2025-Q2 | 5 | 98.62 | 0.55 | 98.72 | +0.10 | |
| SWB-2411-R4540 | Retatrutide | 15 Nov 2024 | 2025-Q1 | 6 | 97.78 | 1.23 | 98.19 | +0.41 | |
| SWB-2411-L5707 | Melanotan II | 01 Nov 2024 | 2025-Q1 | 11 | 99.65 | 1.13 | 99.90 | +0.25 | |
| SWB-2410-V4278 | Enclomiphene citrate | 13 Oct 2024 | 2024-Q4 | 2 | 99.68 | 0.08 | 99.90 | +0.22 | |
| SWB-2409-C6095 | Semaglutide | 15 Sep 2024 | 2024-Q4 | 4 | 98.55 | 0.90 | 99.21 | +0.66 | |
| SWB-2408-T5745 | P21 | 16 Aug 2024 | 2025-Q1 | 4 | 99.20 | 0.95 | 99.78 | +0.58 | |
| SWB-2405-L5945 | NAD+ | 10 May 2024 | 2024-Q3 | 8 | 98.97 | 1.16 | 99.31 | +0.34 | |
| SWB-2403-W5240 | Exenatide | 21 Mar 2024 | 2024-Q3 | 1 | 99.90 | n<2 | 99.90 | 0.00 | |
| SWB-2402-V6189 | Retatrutide | 12 Feb 2024 | 2024-Q3 | 7 | 99.05 | 1.27 | 99.67 | +0.62 | |
| SWB-2311-B4884 | Tirzepatide | 17 Nov 2023 | 2024-Q2 | 4 | 96.88 | 0.94 | 97.30 | +0.42 | |
| SWB-2311-H6137 | PT-141 (Bremelanotide) | 11 Nov 2023 | 2024-Q2 | 7 | 99.10 | 0.82 | 99.66 | +0.56 |